Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

Neurobiology of Disease

Volumn 7, Issue 4, 2000, Pages 321-331

  Refolo, Lorenzo M ^a   Pappolla, Miguel A ^e   Malester, Brian ^a   LaFrancois, John ^a   Bryant Thomas, Tara ^e   Wang, Rong ^b   Tint, G Stephen ^c   Sambamurti, Kumar ^d   Duff, Karen ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL MODEL; ARTICLE; CHOLESTEROL METABOLISM; DIET THERAPY; DISEASE PREDISPOSITION; HYPERCHOLESTEROLEMIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0033833354     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0304     Document Type: Article

References (48)

1. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3
2. The caveolae membrane system
3. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein
4. Cholesterol and mental disorder
5. Cholesterol and the Golgi apparatus
6. Lipoprotein effects on Abeta accumulation and degradation by microglia in vitro
7. Basolateral secretion of amyloid precursor protein in Madin-Darby canine kidney cells is disturbed by alterations of intracellular pH and by introducing a mutation associated with familial Alzheimer's disease
8. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
9. The role of cholesterol in the biosynthesis of beta-amyloid
10. Neurohormonal signaling pathways and the regulation of Alzheimer β-amyloid precursor metabolism
11. Amyloid, the presenilins and Alzheimer's disease
12. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
13. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol
14. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
15. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution
16. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein
17. Genetic influences on age related change in total cholesterol low density lipoprotein cholesterol, triglyceride levels: Longitudinal apolipoprotein E genotype effects
18. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: A case-control study
19. Dietary fat intake and the risk of incident dementia in the Rotterdam Study
20. Effect of liposomes containing cholesterol on adenylate cyclase activity of cultured mammalian fibroblasts
21. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein
22. Elevated low-density lioprotein in Alzheimer's disease correlates with brain abeta 1-42 levels
23. A detergent-insoluble membrane compartment contains A beta in vivo
24. Development expression of wild type and mutant presenilin-1 in hippocampal neurons from transgenic mice: Evidence for novel species-specific properties of human presenilin-1
25. ApoE genotype in relation to AD and cholesterol: A study of 2,326 Chinese adults
26. Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol
27. Cellular actions of beta-amyloid precursor prorein and its soluble and fibrillogenic derivatives
28. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes
29. Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipids
30. Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells
31. Protein and lipid sorting between the endoplasmic reticulum and the Golgi complex
32. Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease
33. Serum cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
34. Apolipoprotein E in the brain and its role in Alzheimer's disease
35. Amyloid and lipids in the pathology of Alzheimer disease
36. Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein
37. Cholesterol domains in biological membranes
38. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons
39. Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease?
40. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
41. Age-related Aβ deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and β amyloid precursor protein is not associated with global neuronal loss
42. Endoproteolysis of presenllin 1 and accumulation of processed derivatives in vivo
43. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
44. The profile of soluble amyloid beta protein in cultured cell media: Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry
45. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid
46. Recent advances in brain cholesterol dynamics: Transport, domains and Alzheimer's disease
47. Relationship between abnormal cholesterol synthesis and retarded learning in rats
48. Modulation of membrane function by cholesterol